Abbott Diagnostics Technologies AS NycoCard™ HbA1c - HSA Registration DE0011566
Access comprehensive regulatory information for Abbott Diagnostics Technologies AS NycoCard™ HbA1c in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0011566 and owned by Abbott Diagnostics Technologies AS. The device was registered on November 08, 2012.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
NycoCard™ HbA1c is an in vitro diagnostic medical device for quantitative determination of glycated haemoglobin (HbA1c) in human whole blood. For monitoring of long term metabolic control in persons with diabetes Mellitus

